Alliance Pharma Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-10.73	-33.14	-21.21	7.32	8.03
Depreciation & Amortization	7.79	8.42	8.8	8.74	8.91
Other Amortization	2.23	2.36	2.61	2	0.58
Loss (Gain) From Sale of Assets	-2.4	-	-	-	0.31
Asset Writedown & Restructuring Costs	36.51	79.25	46.49	6.15	12.06
Stock-Based Compensation	1.65	0.89	0.09	2.25	1.37
Other Operating Activities	-0.24	-12.19	-1.09	7.36	2.86
Change in Accounts Receivable	5.42	-6.48	-18.72	-6.15	6.73
Change in Inventory	3.11	-1.86	-2.21	1.84	-5.21
Change in Accounts Payable	-4.97	1.94	7.28	-0.33	5.93
Change in Other Net Operating Assets	0.34	-7.79	-1.08	9.47	-
Operating Cash Flow	38.72	31.41	20.97	38.66	41.57
Operating Cash Flow Growth	23.26%	49.77%	-45.75%	-7.00%	16.25%
Capital Expenditures	-0.84	-0.7	-0.36	-1.53	-4.61
Cash Acquisitions	-	-0.22	-16.62	0.18	-82.67
Sale (Purchase) of Intangibles	2.84	-	-0.25	-3.26	1.41
Other Investing Activities	0.06	-	0.2	-	0.01
Investing Cash Flow	2.06	-0.92	-17.03	-4.6	-85.86
Long-Term Debt Issued	-	-	14.93	-	82.6
Long-Term Debt Repaid	-22.09	-18.87	-2.22	-23.51	-22.43
Net Debt Issued (Repaid)	-22.09	-18.87	12.7	-23.51	60.17
Issuance of Common Stock	0.02	0.04	0.34	0.74	1.64
Common Dividends Paid	-	-9.59	-9.12	-8.6	-2.84
Other Financing Activities	-8.82	-10.77	-4.8	-2.97	-3.23
Financing Cash Flow	-30.88	-39.19	-0.88	-34.34	55.75
Foreign Exchange Rate Adjustments	0.04	-0.58	-0.42	0.45	-0.38
Net Cash Flow	9.92	-9.28	2.65	0.16	11.07
Free Cash Flow	37.88	30.71	20.61	37.13	36.96
Free Cash Flow Growth	23.32%	49.00%	-44.49%	0.48%	16.90%
Free Cash Flow Margin	21.18%	17.00%	12.31%	22.75%	28.47%
Free Cash Flow Per Share	0.07	0.06	0.04	0.07	0.07
Cash Interest Paid	8.8	9.43	4.8	2.97	2.87
Cash Income Tax Paid	5.58	5.52	3.96	6.26	4.84
Levered Free Cash Flow	32.08	16.84	9.75	37.26	29.5
Unlevered Free Cash Flow	37.35	22.62	12.5	38.9	30.57

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.